Peptide questions · CagriSema
How long does CagriSema take to work?
Reviewed Evidence: EstablishedPublished by PepVault
CagriSema’s onset is days–2 weeks, its peak effect comes at 68+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
The timeline’s basis: Phase 3 REDEFINE 1 and 2 (NEJM 2025), REDEFINE 5 (Lancet Diabetes Endocrinol 2026) and the REDEFINE 4 headline results (Novo Nordisk, 2026). Under FDA review; not approved.
CagriSema week by week
The library places five of its research notes on CagriSema on the days they cover, from day 1 to day 364 and on: 5 on randomized trials.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–28 (weeks 1–4) | The 0.25 mg start | Randomized trial |
| Days 29–364 (weeks 5–52) | 0.5 mg of each | Randomized trial |
| Days 57–364 (weeks 9–52) | 1 mg of each, halfway up | Randomized trial |
| Days 85–364 (weeks 13–52) | 1.7 mg of each, one step from the top | Randomized trial |
| From day 113 on | 2.4 mg/2.4 mg, the maintenance dose | Randomized trial |

Model. Individual results vary.
The CagriSema timeline’s milestones
The library’s timeline for CagriSema marks 7 points from week 1 to week 84, backed by clinical trial data overall.
- Week 1: Commonly reported: appetite dipping within days, with some nausea after the first shots
- Week 4: Trial step from 0.25 to 0.5 mg of each component
- Week 8: Commonly reported: smaller portions and fullness arriving early in a meal
- Week 16: The trials reach the 2.4 mg/2.4 mg maintenance dose here, after four 4-week steps
- Week 24: Commonly reported: GI side effects settling once the dose holds steady
- Week 68: Where REDEFINE 1 and 2 read out
- Week 84: Where the head-to-head with tirzepatide (REDEFINE 4) read out
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why CagriSema takes that long
CagriSema’s half-life is about 7 days (168 hours), so one dose is about 96.9% cleared after 35 days.
On its schedule (Weekly) the doses overlap, and the level of CagriSema keeps climbing for about 28–35 days before it levels off, so the first 28–35 days run below the level the later weeks hold.
The notes on CagriSema follow the trials’ dose steps, 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
CagriSema against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, CagriSema among them; 15 of the others share its onset of days–2 weeks.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does CagriSema take to work?
CagriSema’s onset is days–2 weeks, its peak effect comes at 68+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
When does CagriSema reach its peak effect?
By the library’s timeline, CagriSema’s peak effect comes at 68+ weeks, backed by clinical trial data.
How long is CagriSema usually run?
The library’s timeline gives CagriSema’s typical duration as ongoing; its cycle note says: Studied as an ongoing weekly treatment: 68 to 84 weeks in phase 3.
What does the library say about the first days on CagriSema?
Its first note on CagriSema, for days 1–28 (weeks 1–4), is “The 0.25 mg start”, resting on randomized trials.